Risk of cardiac valve disorders associated with the use of biphosphonates (Cardiac valve disorders and biphosphonate use)

Documents

Study protocol

Initial protocol

D1.b. Final Protocol signal strengthening (BI)_23May2012

Study results

Study results

Executive Summary

Study report

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

This study has been awarded the ENCePP seal

Conflicts of interest of investigators

ENCePPDoIForms_merged

Composition of steering group and observers

Participants_Cardiac valve disorders and biphosphonate use

Signed code of conduct

CoC Declaration 2616

Signed code of conduct checklist

CoC Checklist 2616

Signed checklist for study protocols

Study Protocols Checklist 2616